Developed by the Children’s Tumor Foundation, the Racing4Research™ (R4R) program utilizes competitive, professional auto racing as a vehicle to increase awareness of neurofibromatosis and raise funds for research through corporate sponsorship, personal donations, and individual fundraising by NF Heroes: children and adults from around the country who live with neurofibromatosis. The Racing4Research program offers children and families living with the disorder a unique, one-of-a-kind experience with the teams, drivers and corporate partners, and has raised more than $3.4 million dollars since 2008.
Children's Tumor Foundation
Since its inception in 1978, the Children’s Tumor Foundation has grown into the largest non-government funder of neurofibromatosis, or NF, research in the world. The Foundation is the driving force behind research aimed at finding treatments and a cure for NF – a common, yet under recognized progressive disorder that causes tumors to grow on nerves throughout the body. NF affects one in every 3,000 children, more than cystic fibrosis, Duchenne muscular dystrophy and Huntington’s disease combined, and can lead to a wide variety of complications, including blindness, bone abnormalities, cancer, deafness, disfigurement, learning disabilities and excruciating and disabling pain.Pioneering NF research funded by Children's Tumor Foundation is shedding new light on cancer, brain tumors, learning disabilities, and bone abnormalities – ultimately benefiting the broader community, in addition to those with NF.
In addition to funding world-class research, Children’s Tumor Foundation is committed to ensuring that every dollar raised is put to the very best use to improve the lives of those living with NF. The Foundation is a recipient of a four-star (highest) rating from Charity Navigator – America’s largest independent charity evaluator – and was recently cited in the New York Times for our commitment to financial transparency.
The Children's Tumor Foundation is a non-profit 501(c)(3) medical foundation. For more information, please visit the CTF website.